WCPO: UC scientist finds new solution to fight superbug infections
Professor Hassett takes on some of the nastiest infections resistant to antibiotics
Journalist Paulo Suro speaks with Daniel Hassett, PhD, professor in the UC Department of Molecular Genetics, Biochemistry and Microbiology, about his patented treatment AB569 and its possible use to treat cystic fibrosis, chronic obstructive pulmonary disease and other infections. AB569 tackles some of the nastiest superbugs on the planet and currently being tested in human trials to ensure its safety for future patients.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.